Neurodegenerative Research Exploring potential neuroprotective mechanisms, including its effects on mitochondrial integrity, protein aggregation, and synaptic plasticity in age-related or disease-induced models
The evidence strongly supports implementing early response checkpoints at 4 weeks and prompt medication intervention for non-responders, challenging the traditional approach of prolonged behavioral therapy before pharmacological support
Today, the cost of WES is comparable to what SNP-based panels required years ago
I mean, some of these are just thousands and thousands of dollars per month that are saved, brought down to levels that you wouldn't think would even be conceivable
You're doing everything right, and the scale still won't move
One trial suggests it may help reduce weight in overweight people with diabetes when used as an add on to the anti-obesity drug orlistat [2]